Search research articles
Contact Us
Filters
Showing results (11-20 of 35) with videos related to
Page
of 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
June 28, 2011
Mechanism of von Willebrand factor scissile bond cleavage by a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13)
Yaozu Xiang, Rens de Groot, James T B Crawley, et al.
Frontiers in Molecular Biosciences
|
April 24, 2023
Editorial: ADAM, ADAMTS and astacin proteases: Challenges and breakthroughs in the -Omics era-Volume II
Hang Fai Kwok, Kazuhiro Yamamoto, Rens de Groot, et al.
Ebiomedicine
|
October 2, 2015
Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura
Mari R Thomas, Rens de Groot, Marie A Scully, et al.
The Journal of Biological Chemistry
|
March 31, 2019
Proteomic discovery of substrates of the cardiovascular protease ADAMTS7
Alain Colige, Christine Monseur, James T B Crawley, et al.
Frontiers in Molecular Biosciences
|
October 29, 2021
Editorial: ADAM, ADAMTS and Astacin Proteases: Challenges and Breakthroughs in the -Omics Era
Kazuhiro Yamamoto, Rens de Groot, Simone Dario Scilabra, et al.
Blood
|
February 24, 2009
Essential role of the disintegrin-like domain in ADAMTS13 function
Rens de Groot, Ajoy Bardhan, Nalisha Ramroop, et al.
Journal of Thrombosis and Haemostasis : JTH
|
February 15, 2026
Caplacizumab resistance in immune thrombotic thrombocytopenic purpura (iTTP) associated with VWF A1 domain missense variant
Mari Thomas, Imogen Buckle, Adela Constantinescu-Bercu, et al.
Blood
|
July 1, 2011
Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor
James T B Crawley, Rens de Groot, Yaozu Xiang, et al.
Blood
|
January 31, 2023
Delayed normalization of ADAMTS13 activity in acute thrombotic thrombocytopenic purpura in the caplacizumab era
Nithya Prasannan, Mari Thomas, Matthew Stubbs, et al.
Research and Practice in Thrombosis and Haemostasis
|
April 17, 2023
ADAMTS13 activity testing: evaluation of commercial platforms for diagnosis and monitoring of thrombotic thrombocytopenic purpura
Deepak Singh, Maryam Owais Subhan, Rens de Groot, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 35) with videos related to
Sort By:
Page
of 4
Proceedings of the National Academy of Sciences of the United States of America
|
June 28, 2011
Mechanism of von Willebrand factor scissile bond cleavage by a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13)
Yaozu Xiang, Rens de Groot, James T B Crawley, et al.
Frontiers in Molecular Biosciences
|
April 24, 2023
Editorial: ADAM, ADAMTS and astacin proteases: Challenges and breakthroughs in the -Omics era-Volume II
Hang Fai Kwok, Kazuhiro Yamamoto, Rens de Groot, et al.
Ebiomedicine
|
October 2, 2015
Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura
Mari R Thomas, Rens de Groot, Marie A Scully, et al.
The Journal of Biological Chemistry
|
March 31, 2019
Proteomic discovery of substrates of the cardiovascular protease ADAMTS7
Alain Colige, Christine Monseur, James T B Crawley, et al.
Frontiers in Molecular Biosciences
|
October 29, 2021
Editorial: ADAM, ADAMTS and Astacin Proteases: Challenges and Breakthroughs in the -Omics Era
Kazuhiro Yamamoto, Rens de Groot, Simone Dario Scilabra, et al.
Blood
|
February 24, 2009
Essential role of the disintegrin-like domain in ADAMTS13 function
Rens de Groot, Ajoy Bardhan, Nalisha Ramroop, et al.
Journal of Thrombosis and Haemostasis : JTH
|
February 15, 2026
Caplacizumab resistance in immune thrombotic thrombocytopenic purpura (iTTP) associated with VWF A1 domain missense variant
Mari Thomas, Imogen Buckle, Adela Constantinescu-Bercu, et al.
Blood
|
July 1, 2011
Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor
James T B Crawley, Rens de Groot, Yaozu Xiang, et al.
Blood
|
January 31, 2023
Delayed normalization of ADAMTS13 activity in acute thrombotic thrombocytopenic purpura in the caplacizumab era
Nithya Prasannan, Mari Thomas, Matthew Stubbs, et al.
Research and Practice in Thrombosis and Haemostasis
|
April 17, 2023
ADAMTS13 activity testing: evaluation of commercial platforms for diagnosis and monitoring of thrombotic thrombocytopenic purpura
Deepak Singh, Maryam Owais Subhan, Rens de Groot, et al.
Page
of 4